Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

Clinical trial suggest BARDA-supported long-acting antibody combo can prevent COVID-19 …,

The clinical trial met its primary endpoint, reducing the risk of symptomatic COVID-19 by 77% for at least three months when administered prior to infection …, The clinical trial met its primary endpoint, reducing the risk of symptomatic COVID-19 by 77% for at least three months when administered prior to infection …, Read More

Scroll to Top